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Abstract
COLOSTRONONI is a dietary supplement consisting of bovine colostrum and Morinda citri-
folia fruit (Noni). In this study, we tested the capability of COLOSTRONONI to influence gut
microbiota composition using an in vivo evaluation in rats. Furthermore, we analyzed the
effect of COLOSTRONONI on the systemic inflammatory responses as well as on the gut
permeability of the animals. Altogether, our analyses supported the concept of COLOSTRO-
NONI as a natural food supplement that doesn’t affect (neither negatively nor positively) gut
microbiota homeostasis in healthy conditions. Moreover, COLOSTRONONI highlighted a
lower effect in the expression of genes coding for IL-10, Il-12 and TNF-α response allowing
us to hypothesize an immunomodulatory activity of this dietary supplement.
Introduction
COLOSTRONONI is a new dietary supplement consisting of bovine colostrum and Morinda
citrifolia fruit (Noni) [1]. Several scientific evidences suggested that bovine colostrum and
noni fruit exert regulatory effects which prevent intestinal inflammation conditions and, con-
sequently, are able to reduce the develop of inflammatory-based chronic systemic diseases [1].
Colostrum is the first milk collected from a lactating mammal gland after delivery. It repre-
sents a unique aspect to nutrition of newborns, in fact it is able to promote the development of
microbial composition of gastrointestinal tract as well as the immune system through the
acquisition of maternal immunoglobulins [2]. Bovine colostrum is rich in inflammatory cyto-
kines including interleukins (IL-2, IL-1β, IL-6, IL-17) and immunoglobulins, such as IgA, IgM
and IgG, tumor necrosis factor-α (TNF-α), interferon-γ, and other not antimicrobial com-
pounds contributing to protect the organism against pathogenic microorganism infections [3,
4]. In addition, the bovine colostrum encompasses components involved in the innate
immune system like antimicrobial peptides as well as lactoferrin and lactoperoxidases, display-
ing additive antibacterial effects [4, 5].
The Morinda citrifolia L., also known as Noni, is a plant producing more than 160 identified
phytochemicals, which is native to the Indian Ocean and Polynesia and it is widely distributed
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around the world [6]. Biological compounds such as glycosides, polysaccharides, trisaccharide
fatty acid esters, vitamins, and minerals have been isolated from noni fruits, roots, and leaves
[7]. Recent studies revealed that juice made extract from the M. citrifolia fruit (Noni) possesses
a broad range of immunomodulatory effects, including antibacterial, anti-inflammatory, anti-
tumorigenesis, and antioxidant activities [7–11].
The intestinal barrier is able to regulate the absorption of nutrients and the exchange of
molecules between the host and environmental [12]. Specifically, the inter-endothelial tight
junctions (TJs) play a critical role in the permeability of the endothelial barrier [13]. In particu-
lar, TJs connect neighboring cells with each other to create a barrier that prevents pathogen
infections as well as regulates paracellular diffusion of ions and solutes [14].
The aim of this study was the evaluation of the influence of COLOSTRONONI on the over-
all microbial biodiversity in the gut of rats, in order to identify a putative effect of this dietary
supplement on specific bacterial groups. Furthermore, in this study we assessed the effect of




All experimental procedures and protocols involving animals were approved by the Veterinar-
ian Animal Care and Use Committee of Parma University (number 370/2018) and conducted
in accordance with the European Community Council Directives dated 22 September 2010
(2010/63/UE).
Animal housing
Experiments involved three-month-old male wild-type Groningen rats (Rattus norvegicus),
originally obtained from the University of Groningen (The Netherlands), and bred in animal
facilities under standard conditions. After weaning, rats were housed in same sex sibling
groups in rooms under humidity-(50 ± 10%) and temperature (22 ± 2˚C) controlled condi-
tions, a 12-h light–dark cycle (lights on at 7 a.m.), and with food and water available ad
libitum.
COLOSTRONONI description
COLOSTRONONI is a dietary supplement consisting of 30.56% of bovine colostrum and
11,11% of Morinda citrifolia fruit juice (Noni) (S1 Table). The manufacturing process flow
sheet (Colostrononi 2205C02) is displayed in S1 Fig. The list of all ingredients is described in
S1 Table. Moreover, the quality control is performed by Verdellino Laboratory, Italy and the
number of analytic certificate was 201727122. The details concerning the quality check are
described in S2 Table. The stability experiments revealed that the shelf life of COLOSTRO-
NONI is 36 months (S3 Table). Moreover, the product was storaged in cool and dry place, pro-
tected from direct sunlight.
Finally, the chemical characterizations of Bovine Colostrum and Morinda citrifolia fruit
juice are provided in S4 and S5 Tables.
Experimental design of the in vivo experiments
The timeline of all procedures is illustrated in Fig 1. In detail, rats were housed individually in
polymethyl methacrylate (Plexiglas) cages (39 cm × 23 cm × 15 cm). During the first week, ani-
mals continued to follow a normal chow diet but received daily oral administration of a 2%
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sucrose solution (volume: 500μl), in order to train them to drink spontaneously from a syringe.
Subsequently, rats were randomized in two groups (n = 10 each) and were either fed with a
standard diet supplemented with COLOSTRONONI (Product Number 934744602, Lot #
A04268, Guna S.p.a., Milan, Italy) dissolved in sucrose solution (2%) (CN group) [0.500 gr/kg
(w/w)], or maintained with a standard diet supplemented with sucrose solution (2%) (CTRL
group) for the following 12 days. Finally, at the end of experimental protocol, the rats were
euthanized. Furthermore, in order to evaluate the influence of COLOSTRONONI treatment
in gut microbiota composition of rats we have collected the faecal samples at three different
time points before (T0), during (T1) and after (T2) treatment (Fig 1). At the same time-points,
BW was measured and BW changes were calculated as previously described [15].
Faecal and cecal bacterial DNA extraction
Faecal samples were subjected to DNA extraction using the QIAmp DNA Stool Mini Kit fol-
lowing the manufacturer’s instructions (Qiagen). Furthermore, bacterial DNA extraction from
cecal samples was performed using PowerViral Environmental RNA/DNA Isolation Kit Sam-
ple (Qiagen) following the protocol’s instruction. DNA concentration and purity were then
determined with a Picodrop microlitre Spectrophotometer (Picodrop).
Fig 1. Timeline and results of the experimental procedure. Panel A shows the schedule of the experimental procedures. Panel B and C display the
body weight and food intake percentage changes relative to the respective ‘T0’ values, during the experiment, respectively. Values are expressed as
means ± standard error of mean (SEM).
https://doi.org/10.1371/journal.pone.0217609.g001
COLOSTRONONI and gut microbiota composition
PLOS ONE | https://doi.org/10.1371/journal.pone.0217609 May 31, 2019 3 / 13
16S rRNA gene amplification and sequencing
Partial 16S rRNA gene sequences were amplified from extracted DNA using primer pair Pro-
bio_Uni and/Probio_Rev, which targets the V3 region of the 16S rRNA gene sequence [16].
Illumina adapter overhang nucleotide sequences are added to the partial 16S rRNA gene-spe-
cific amplicons, which were the further processed employing the 16S Metagenomic Sequenc-
ing Library Preparation Protocol (Part #15044223 Rev. B–Illumina; see also below). In
accordance with the Illumina protocols, PCR products obtained following amplification of the
16S rRNA gene sequences were purified by magnetic purification step involving the Agencourt
AMPure XP DNA purification beads (Beckman Coulter Genomics GmbH, Bernried, Ger-
many) in order to remove primer dimers. DNA concentration of the amplified sequence
library was estimated through fluorimetric Qubit quantification system (Life Technologies).
Amplicons were diluted to 4 nM and 5 μl of each diluted DNA amplicons were mixed to pre-
pare the pooled final library. Sequencing was performed using an Illumina MiSeq sequencer
with MiSeq Reagent Kit v3 chemicals.
16S rRNA-microbial profiling analysis
Following sequencing, the. fastq files were processed using a custom script based on the
QIIME software suite [17]. Paired-end reads pairs were assembled to reconstruct the complete
Probio_Uni / Probio_Rev amplicons. Quality control retained sequences with a length
between 140 and 400 bp and mean sequence quality score >20 while sequences with homopol-
ymers>7 bp and mismatched primers were omitted. In order to calculate downstream diver-
sity measures (alpha and beta diversity indices, Unifrac analysis), 16S rRNA Operational
Taxonomic Units (OTUs) were defined at� 99% sequence homology using uclust [18] and
OTUs with less than 10 sequences were filtered. All reads were classified to the lowest possible
taxonomic rank using QIIME [17] and a reference dataset from the SILVA database [19] for
16S rRNA data. Biodiversity of the samples (alpha-diversity) was calculated with Chao1 and
Shannon indexes. Similarities between samples (beta-diversity) were calculated by weighted
and unweighted uniFrac [20]. The range of similarities is calculated between the values 0 and
1. PCoA representations of beta-diversity were performed using QIIME [17].
Statistical analyses
PERMANOVA analysis was performed, using QIIME [17] to evaluate the differences in
microbiota composition between CN and CTRL group. All data were presented as means ± S.
E.M. Comparison between the two groups were made using un-paired Student’s t-test.
Observed differences corresponding to P<0.05, P<0.01 and P<0.001 were considered, respec-
tively, statistically significant, highly significant or extremely highly significant. All analyses
were performed using Prism 5 software (GraphPad Software Inc. San Diego, CA).
RNA isolation and gene expression
Total RNA was isolated starting from 1 gr of caeca tissue that was suspended in 1 ml of QIA-
zoL (Qiagen, UK) and placed in a tube containing 0.8 g of glass beads (diameter, 106 μm;
Sigma). The cells were lysed by shaking the mix on a BioSpec homogenizer at 4˚C for 2 min
(maximum setting). The mixture was then centrifuged at 12,000 rpm for 15 min, and the
upper phase containing the RNA-containing sample was recovered. The RNA sample was fur-
ther purified by RNeasy Mini Kit (QIAGEN) following the specific protocols. The quality of
the RNA was checked by analysing the integrity of rRNA molecules by the MultiTape Station
(Agilent). Reverse transcription to cDNA was performed with the iScript Select cDNA
COLOSTRONONI and gut microbiota composition
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synthesis kit (Bio-Rad Laboratories) according to the supplier’s instructions. The mRNA
expression levels were analyzed with SYBR green technology in quantitative real-time PCR
(qRT-PCR) using QPCR Green Master Mix LRox (Biotech Rabbit GmbH) on a Bio-Rad
CFX96 system according to the manufacturer’s instructions (Bio-Rad). The primers used are
indicated in S6 Table in the supplemental material. Quantitative PCR was carried out accord-
ing to the following cycle: initial hold at 96˚C for 30 s and then 42 cycles at 96˚C for 15 s and
Tm˚C for 30 s. Statistical significance between means was analyzed using the unpaired Student
t test with a threshold P< 0.05. Values are expressed as the means ± the SEMs of rats of each
group. Statistical calculations were performed using the software program GraphPad Prism 5.
Data deposition
Raw sequences of 16S rRNA gene profiling are accessible through SRA study accession num-
bers PRJNA497777.
Results and discussion
Animal growth and food intake
In order to evaluate if COLOSTRONONI is able to modulate rat physiological conditions, we
performed an in vivo experiment using two groups of rats, one receiving COLOSTRONONI
(CN) in their diet and the other maintained on a standard diet (CTRL). The effect of COLOS-
TRONONI on the body weight (BW), as well as on Food Intake (FI) of the animals was
recorded (Fig 1).
Two-way ANOVA for repeated measures yielded a significant effect of time for BW
(F = 232.09, p-value< 0.001) and FI/BW (F = 22.40, p-value < 0.001) changes. BW increased
similarly in both groups during the experimental protocol. Likewise, no significant differences
between the two groups were found in FI changes. Noteworthy, FI appears to increase only
during the first week of CN/CTRL condition (CN: + 3.17%; CTRL: + 4.12%).
These data show that COLOSTRONONI treatment does not influence BW growth as well
as FI in rats.
Characterization of the effects of COLOSTRONONI on the gut microbiota
composition of rats
Fecal and caecal samples were used to determine the microbiota taxonomic profile associated
with COLOSTRONONI dietary supplement or not by means of 16S rRNA-sequencing analy-
sis as described previously [16]. Next Generation sequencing of the 80 samples, including fecal
samples at different time points and caecal samples, produced a total of 5,727,788 reads, rang-
ing from 43,050 to 92,936 per sample (S7 Table). Quality and chimera filtering led to a total of
4,863,323 filtered reads with an average of 60,791 and ranging from 27,534 to 82,880 reads per
sample (S7 Table). Chao1 biodiversity curves suggesting that in all cases the obtained sequenc-
ing depth was appropriate to cover the large majority of the microbiota biodiversity contained
in the samples (Fig 2A and 2B). Notably, CN supplementation was not associated with evident
alterations and/or reduction of the biodiversity of the gut microbiota in the caecal samples as
well as in fecal samples during all treatment periods (p -value> 0.05 calculated through un-
paired Student’s t-test) (Fig 2C). In order to evaluate the rat microbiota differences between
CN and CTRL groups, we analyzed the beta-diversity based on unweighted and weighted Uni-
Frac for these groups, followed by Principal Coordinate Analysis (PCoA) (Fig 3). The PCoA
analyses were performed on fecal samples at different time point as well as on the caecal sam-
ples, separately. These data highlight the occurrence, for both groups, of only one cluster (Fig
COLOSTRONONI and gut microbiota composition
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3), which suggest a maintenance of the stability of gut microbiota composition. Notably, these
results were also validated by the PERMANOVA statistical analysis (p-value > 0.05) (Fig 3).
The caecal microbiota composition of rats was shown to be dominated by the Firmicutes
phylum (average value 79.92%), followed by Bacteroidetes (average values 18.07%). Con-
versely, the analysis of fecal microbiota composition highlighted a high abundance of Bacteroi-
detes (average value 62.27) and Firmicutes phylum (average values 36.61%). The most
abundant bacterial taxa were Bacteroidales S24-7 group family (15.67% and 54.29% in caecal
samples and in fecal samples, respectively) and two different genera belonging to Lachnospira-
ceae family (total average of 41.00% 18.14% in caecal samples and in fecal samples, respec-
tively) (Figs 4 and 5). The comparison of the microbiota of caecal and fecal samples belonging
to CN and CTRL rats, respectively, indicated no significant differences in the microbiota com-
position between each groups. These results support the hypothesis that COLOSTRONONI
product does not affect (neither negatively nor positively) the gut microbiota homeostasis in
healthy conditions, maintaining the equilibrium between the different bacterial taxa constitut-
ing the gut microbiota. Focusing on the genus Akkermansia, i.e., Akkermansia muciniphila,
which was reported to exert health-promoting activities through the modulation of the host
immune system and by the proliferation of anti-inflammatory regulatory T cells, we observed
Fig 2. Alpha-diversity of CN and CTRL group. Panels a and b report average alpha-diversity obtained using Chao1 index for cecal and faecal samples, respectively.
Panel c shows box and whisker plot. The bands inside the box are the median, the ends of the whisker represent the minimum and the maximum of all the data.
https://doi.org/10.1371/journal.pone.0217609.g002
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a slight increase of this genus in the CN treated fecal samples (relative abundance average of
0.66% ± 1.80%, 1.97% ± 4.20% and 1.39% ± 3.19% in T0, T1 and T2, respectively) compared
with the control group (relative abundance average of 0.02% ± 0.05%, 0.22% ± 0.53% and
0.12% ± 0.30% in T0, T1 and T2, respectively) [21]. In detail, the prevalence obtained from the
Fig 3. Beta diversity analysis of fecal and cecal samples. Panel a and b consists in a PCoA illustrating the beta-diversity of
CN and CTRL cecal samples calculated through unweighted and weighted UniFrac, respectively. Panel c and d shows in a
PCoA reporting the beta-diversity of CN and CTRL fecal samples calculated through unweighted and weighted UniFrac,
respectively. It has also been reported the p-value calculated through a PERMANOVA analyses.
https://doi.org/10.1371/journal.pone.0217609.g003
COLOSTRONONI and gut microbiota composition
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comparison of each sample T0 with the respective T1 or T2 sample in the CN group revealed
an increase of this taxon in 50% of cases (6 samples T1 and 4 samples T2) (Fig 5). In contrast,
the prevalence of the comparison of each sample T0 with the respective T1 or T2 sample in the
CTRL group revealed an increase of this taxon in only 25% of cases (3 samples T1 and 2 sam-
ples T2) (Fig 5).
Identification of molecular effects of COLOSTRONONI on the systemic
inflammatory responses
In order to explore the impact of COLOSTRONONI on cytokines expression in rats, we evalu-
ated the induction of genes encoding for IL-10, IL-12, IL-8 and TNF-α by using a qRT-PCR
approach. In this context, we observed different cytokine expression between the rats supple-
mented with CN and the CTRL group [rats supplemented with sucrose solution (2%)].
The results of gene expression assays on healthy rat cecal tissue show that a significant
reduction of IL-10, IL-12 and TNF-α expression levels was detectable in the CN group.Particu-
larly interesting is the evaluation of the ratios between IL-10 and IL-12 and between TNF-α
and IL-10.
Fig 4. 16S rRNA profiling of CN and CTRL rat cecal and fecal samples. Bar plots show the average of relative abundance variation in CN respect to CTRL rats at
genus level. Only taxa with average relative abundance> 1% in these groups are shown.
https://doi.org/10.1371/journal.pone.0217609.g004
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IL-10/IL-12 ratio (about 1:1, under normal conditions) [22, 23], is currently investigated as
a marker for inflammatory diseases and/or dysbiosis. It is also useful for the evaluation of the
effects of supplementation with probiotics (increased ratio due to increased expression of IL-
10) [23, 24]. The highlighted simultaneous reduction of IL-12 and IL-10 (74 and 78 folds
respectively) (Fig 6) preserves the normal IL-10/IL-12 ratio, in agreement with the lack of
changes in the microbiota composition in the two experimental groups.
TNF-α/IL-10 ratio is reduced in CN group compared with the CTRL one; this result, due to
the positive “delta” between TNF-α (-97 folds) and IL-10 gene expression reduction (23 folds
in favor of IL-10) (Fig 6) may be considered as a marker of an anti-inflammatory activity of
COLOSTRONONI.
Interestingly, COLSTRONONI seems to modulate inflammatory response by a refined reg-
ulation of both TNF-α and IL-10 gene expression instead of inducing the up-regulation of IL-
10. The simultaneous reduction of TNF-α, IL-10, and IL-12 gene expression allow us to
hypothesize that COLOSTRONONI in healthy subject plays an important role in immunomo-
dulation mechanisms through a slight reduction of physiological inflammation (low TNF-α
levels and reduced TNF-α/IL-10 ratio) preserving, at the same time, the physiological mecha-
nism of immunotolerance (maintenance of IL-10/IL-12 ratio).
Fig 5. 16S rRNA profiling of CN and CTRL rats cecal and fecal samples. Bar plot show the relative abundance variation in CN respect to CTRL rats at genus level for
each animal. Only taxa with average relative abundance> 1% in these groups are shown. Heat map on the top of bar plot shows the increase/decrease of the genus
Akkermansia.
https://doi.org/10.1371/journal.pone.0217609.g005
COLOSTRONONI and gut microbiota composition
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Impact of COLOSTRONONI on cell permeability
The primary constituents in the transmembrane group include the claudins, occludin, and
junctional adhesion molecules (JAMs) [25]. These several gut permeability markers were eval-
uated by qRT-PCR. These data highlighted no significant differences in the gene expression
for claudins (claudin-1, claudin-2 and claudin-5), as well as JAM-A and occludin, in rats
treated with COLOSTRONONI (CN group) respect to in non-treated rats (CTRL group).
These data suggest that the supplementation of COLOSTRONONI could not influence the gut
permeability of healthy rats. However, it is worth mentioning that under healthy conditions
the level of expression of TJs genes is normally not modified.
Conclusion
The evaluation of the potential dietary supplement features of COLOSTRONONI under in
vivo conditions revealed the ability of this dietary supplement to preserve the gut microbiota
climax as well as its influences on the mammalian host innate immunity. Furthermore, the
COLOSTRONONI treatment provoked a slight increase of the genus Akkermansia. Interest-
ingly, A. muciniphila is an intestinal bacterium, which has been proposed as a novel health-
promoting bacterial species due to its immunomodulatory properties.
COLOSTRONONI also showed a significant lowering effect in the expression of genes cod-
ing for IL-10, Il-12 and TNF-α response which allows us to hypothesize an immunomodula-
tory activity of this dietary supplement. It is remarkable that TNF-α mediates changes in
goblet cell expression and mucin sulfation, and that its production is inversely correlated with
epithelial permeability [26, 27]. Interestingly, the reduction of TNF-α gene expression in the
CN group probably improved the mucus synthesis., which consequently could promote a
slight increase of A. muciniphila.
COLOSTRONONI does not influence the IL-8 expression; this result is in agreement with
the observed maintenance of normal epithelial integrity, which is confirmed by the absence of
modulation of genes enconding for claudins, occludin and JAMs, whose expression has been
shown to be regulated in dose-dependent manner by IL-8 itself [27]. These results reinforce
the concept that bovine colostrum and M. citrifolia influence the mammalian host innate
immunity.
Fig 6. Evaluation of the expression of rat cytokines. Horizontal level represents the medians. The y axis represents
the level of expression as normalized expression (ΔΔCt) according to CFX96 Bio-Rad software.
https://doi.org/10.1371/journal.pone.0217609.g006
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Future studies should be performed using different amounts of COLOSTRONONI in order
to assess if the homeostatic role of this dietary supplements toward the mammalian gut micro-
biota is dose-dependent.
In addition, it will be interesting to evaluate if the homeostatic role of COLOSTRONONI
on the gut microbiota is also exploited under acute inflammatory conditions as those occur-
ring during Inflammatory Bowel Disease (IBD). In this context, a recent study involving an
IBD murine model treated with bovine colostrum (BC) demonstrated an interesting protective
role on the gut microbiota of animal driven by BC [28]. So far, we do not know if the here
identified effects of COLOSTRONONI on the gut microbiota in healthy rats will be also valid
in animals displaying IBD symptoms.
In this context, future in vivo clinical trials will be pivotal to confirm the role of COLOS-
TRONONI on gut microbiota composition in subjects with inflammatory bowel disease
(IBD), such as ulcerative colitis and Crohn disease.
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